Dr.Subodh Agarwal Memorial Eyecare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.53 M
as on 10-12-2024
- Revenue 131.47%
(FY 2019)
- Profit 167.78%
(FY 2019)
- Ebitda 142.20%
(FY 2019)
- Net Worth 26.13%
(FY 2019)
- Total Assets 231.38%
(FY 2019)
About Dr.Subodh Agarwal Memorial Eyecare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.53 M.
Samarth Agarwal and Arti Elhence serve as directors at the Company.
- CIN/LLPIN
U85191UP2013PTC059771
- Company No.
059771
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr.Subodh Agarwal Memorial Eyecare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samarth Agarwal  | Managing Director | 26-Sep-2013 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arti Elhence | Director | 20-Aug-2015 | Current |
Financial Performance of Dr.Subodh Agarwal Memorial Eyecare.
Dr.Subodh Agarwal Memorial Eyecare Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 131.47% increase. The company also saw a substantial improvement in profitability, with a 167.78% increase in profit. The company's net worth Soared by an impressive increase of 26.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Subodh Agarwal Memorial Eyecare?
In 2019, Dr.Subodh Agarwal Memorial Eyecare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Sep 2019 | ₹1.95 M | Open |
Others Creation Date: 31 Jul 2019 | ₹2.58 M | Open |
How Many Employees Work at Dr.Subodh Agarwal Memorial Eyecare?
Unlock and access historical data on people associated with Dr.Subodh Agarwal Memorial Eyecare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Subodh Agarwal Memorial Eyecare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Subodh Agarwal Memorial Eyecare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
